Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
October 2012 Volume 4 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October 2012 Volume 4 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer

  • Authors:
    • Ying Chen
    • Qingqu Guo
    • Bo Zhang
    • Muxing Kang
    • Qiuping Xie
    • Yulian Wu
  • View Affiliations / Copyright

    Affiliations: Department of Surgery, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China
  • Pages: 792-798
    |
    Published online on: July 2, 2012
       https://doi.org/10.3892/ol.2012.783
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Bufalin, an active component of the Chinese medicine chan'su, has been reported to have an inhibitory effect on the growth of various types of cancer cells. In the present study, we investigated whether gemcitabine combined with bufalin enhanced the antitumor efficacy in pancreatic cancer. Three pancreatic cancer cell lines (Bxpc-3, Mia PaCa-2 and Panc-1) were treated with gemcitabine and/or bufalin in vitro. The combination treatment demonstrated greater inhibition of cellular growth and apoptosis. The activity of apoptosis signal-regulating kinase 1 (ASK1)/JNK was upregulated in gemcitabine-induced apoptosis when combined with bufalin. We also observed that tumor growth was significantly inhibited by the combination therapy in a tumor-bearing mouse model, and upregulation of ASK1 activity was validated by immunohistochemical staining. These results suggest that bufalin may be a potential chemotherapeutic agent for pancreatic cancer, which could enhance the antitumor efficacy of gemcitabine when used in combination, possibly through the activation of ASK1/JNK.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1. 

A JemalR SiegelE WardCancer statistics, 2006CA Cancer J Clin56106130200610.3322/canjclin.56.2.106

2. 

AN ShahJM SummyJ ZhangSI ParkNU ParikhGE GallickDevelopment and characterization of gemcitabine-resistant pancreatic tumor cellsAnn Surg Oncol1436293637200710.1245/s10434-007-9583-517909916

3. 

A JemalT MurrayA SamuelsA GhafoorE WardMJ ThunCancer statistics, 2003CA Cancer J Clin53526200310.3322/canjclin.53.1.5

4. 

TS RiallWH NealonJS GoodwinPancreatic cancer in the general population: Improvements in survival over the last decadeJ Gastrointest Surg1012121223discussion 1223–1214, 2006.

5. 

HL PearceM Alice MillerThe evolution of cancer research and drug discovery at Lilly Research LaboratoriesAdv Enzyme Regul45229255200510.1016/j.advenzreg.2005.02.01716143373

6. 

Y ShenM CaiW XiaFTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cellsCancer Lett254288297200710.1016/j.canlet.2007.03.01317462818

7. 

SH LeeJK RyuKY LeeEnhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancerCancer Lett2593949200810.1016/j.canlet.2007.09.01517967505

8. 

HA Burris IIIMJ MooreJ AndersenImprovements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trialJ Clin Oncol152403241319979196156

9. 

K KimuraT SawadaM KomatsuAntitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabineClin Cancer Res1249254932200610.1158/1078-0432.CCR-06-054416914581

10. 

M WatabeN KawazoeY MasudaS NakajoK NakayaBcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cellsCancer Res57309731001997

11. 

N TakaiT UedaM NishidaK NasuH NaraharaBufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cellsInt J Mol Med21637643200818425357

12. 

CH YuSF KanHF PuE Jea ChienPS WangApoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cellsCancer Sci9924672476200810.1111/j.1349-7006.2008.00966.x19037992

13. 

K NasuM NishidaT UedaBufalin induces apoptosis and the G0/G1 cell cycle arrest of endometriotic stromal cells: a promising agent for the treatment of endometriosisMol Hum Reprod11817823200510.1093/molehr/gah24916390854

14. 

CT KuoBC ChenCC YuApoptosis signal-regulating kinase 1 mediates denbinobin-induced apoptosis in human lung adenocarcinoma cellsJ Biomed Sci1643200910.1186/1423-0127-16-4319405983

15. 

W SchonerG Scheiner-BobisEndogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growthAm J Physiol Cell Physiol293C509536200710.1152/ajpcell.00098.200717494630

16. 

Y AmanoY ChoM MatsunawaK KomiyamaM MakishimaIncreased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cellsJ Steroid Biochem Mol Biol114144151200910.1016/j.jsbmb.2009.01.022

17. 

ZY TangYL WuSL GaoHW ShenEffects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cellsJ Surg Res145111123200810.1016/j.jss.2007.03.06117714734

18. 

Q GuoY ChenB ZhangM KangQ XieY WuPotentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with survivin inhibitionBiochem Pharmacol7716741683200910.1016/j.bcp.2009.02.02119428321

19. 

M KornmannHG BegerKH LinkChemosensitivity testing and test-directed chemotherapy in human pancreatic cancerRecent Results Cancer Res161180195200310.1007/978-3-642-19022-3_1512528808

20. 

A ZalatnaiJ MolnarReview. Molecular background of chemoresistance in pancreatic cancerIn Vivo21339347200717436586

21. 

M MimeaultR HaukeSK BatraRecent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapiesClin Pharmacol Ther83673691200810.1038/sj.clpt.610029617786164

22. 

L SunT ChenX WangY ChenX WeiBufalin induces reactive oxygen species dependent bax translocation and apoptosis in ASTC-a-1 cellsEvid Based Complement Alternat Med200919592481

23. 

CM XieWY ChanS YuJ ZhaoCH ChengBufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activationFree Radic Biol Med5113651375201110.1016/j.freeradbiomed.2011.06.016

24. 

K OkamotoM OckerD Neureiterbcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cellsJ Cell Mol Med11349361200710.1111/j.1582-4934.2007.00013.x17378914

25. 

M KurosawaS NumazawaY TaniT YoshidaERK signaling mediates the induction of inflammatory cytokines by bufalin in human monocytic cellsAm J Physiol Cell Physiol278C500508200010712238

26. 

N KawazoeM WatabeY MasudaS NakajoK NakayaTiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cellsOncogene1824132421199910.1038/sj.onc.120255510229192

27. 

M KurosawaY TaniS NishimuraS NumazawaT YoshidaDistinct PKC isozymes regulate bufalin-induced differentiation and apoptosis in human monocytic cellsAm J Physiol Cell Physiol280C459C464200111171564

28. 

T HataiA MatsuzawaS InoshitaExecution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activationJ Biol Chem2752657626581200010.1074/jbc.M00341220010849426

29. 

H IchijoE NishidaK IrieInduction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathwaysScience2759094199710.1126/science.275.5296.908974401

30. 

S NumazawaMA ShinokiH ItoT YoshidaY KuroiwaInvolvement of Na+,K(+)-ATPase inhibition in K562 cell differentiation induced by bufalinJ Cell Physiol1601131201994

31. 

Y JingM WatabeS HashimotoS NakajoK NakayaCell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cellsAnticancer Res141193119819948074471

32. 

Y MasudaN KawazoeS NakajoT YoshidaY KuroiwaK NakayaBufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cellsLeuk Res19549556199510.1016/0145-2126(95)00031-I7658701

33. 

F SuH LiC YanB JiaY ZhangX ChenDepleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cellsJ Cancer Res Clin Oncol13516551663200910.1007/s00432-009-0612-619513748

34. 

CC YuMJ HsuML KuoThrombin-induced connective tissue growth factor expression in human lung fibroblasts requires the ASK1/JNK/AP-1 pathwayJ Immunol18279167927200910.4049/jimmunol.080158219494316

35. 

K YamamotoH IchijoSJ KorsmeyerBCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/MMol Cell Biol1984698478199910567572

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen Y, Guo Q, Zhang B, Kang M, Xie Q and Wu Y: Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer. Oncol Lett 4: 792-798, 2012.
APA
Chen, Y., Guo, Q., Zhang, B., Kang, M., Xie, Q., & Wu, Y. (2012). Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer. Oncology Letters, 4, 792-798. https://doi.org/10.3892/ol.2012.783
MLA
Chen, Y., Guo, Q., Zhang, B., Kang, M., Xie, Q., Wu, Y."Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer". Oncology Letters 4.4 (2012): 792-798.
Chicago
Chen, Y., Guo, Q., Zhang, B., Kang, M., Xie, Q., Wu, Y."Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer". Oncology Letters 4, no. 4 (2012): 792-798. https://doi.org/10.3892/ol.2012.783
Copy and paste a formatted citation
x
Spandidos Publications style
Chen Y, Guo Q, Zhang B, Kang M, Xie Q and Wu Y: Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer. Oncol Lett 4: 792-798, 2012.
APA
Chen, Y., Guo, Q., Zhang, B., Kang, M., Xie, Q., & Wu, Y. (2012). Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer. Oncology Letters, 4, 792-798. https://doi.org/10.3892/ol.2012.783
MLA
Chen, Y., Guo, Q., Zhang, B., Kang, M., Xie, Q., Wu, Y."Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer". Oncology Letters 4.4 (2012): 792-798.
Chicago
Chen, Y., Guo, Q., Zhang, B., Kang, M., Xie, Q., Wu, Y."Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer". Oncology Letters 4, no. 4 (2012): 792-798. https://doi.org/10.3892/ol.2012.783
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team